姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Xu,Long-Lun | Chairman | 55.45% | ASROCK INC. |
Zheng,Guang-Zhi | Director | 55.45% | ASROCK INC. |
Sha,Wei-Xu | Director | 1.75% | |
Chen,Shi-Ren | Director | 1.39% | |
Chen,Bai-Zhu | Independent Director | 0.00% | |
Cai,Pei-Yun | Independent Director | 0.00% | |
Lin,Jian-Zhong | Independent Director | 0.00% |
項目 | 2024 | 2023 |
---|---|---|
Operating income | 2,516,156 | 2,737,906 |
Operating cost | 1,906,705 | 2,014,268 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - |
Operating gross profit (loss) | 609,451 | 723,638 |
Unrealized profit (loss) on sales of goods | - | - |
Realized profit (loss) on sales of goods | - | - |
Operating gross profit (loss), net | 609,451 | 723,638 |
Operating expenses | 443,158 | 731,418 |
Other gain (loss), net | - | - |
Operating profit (loss) | 166,293 | -7,780 |
Non-operating income and expenses | 37,782 | 17,664 |
Net profit (loss) before tax | 204,075 | 9,884 |
Income tax expense (benefits) | 40,815 | 1,977 |
Net profit (loss) of ongoing business for the current period | 163,260 | 7,907 |
Profit (loss) of closed units | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - |
Net profit (loss) for the current period | 163,260 | 7,907 |
Other comprehensive profit (loss), net | - | - |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - |
Total comprehensive profit and loss for the current period | 163,260 | 7,907 |
Net profit (loss) attributable to owners of parent company | - | - |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - |
Net profit (loss) attributable to non-controlling interests | - | - |
Comprehensive profit (loss) attributable to owners of parent company | - | - |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - |
Basic earnings per share (yuan) | 2 | 0 |
項目 | 2024 | 2023 |
---|---|---|
Net cash inflow (outflow) from operating activities | - | - |
Net cash inflows (outflows) from investing activities | - | - |
Net cash inflow (outflow) from financing activities | - | - |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - |
Increase (decrease) in cash and cash equivalents in the current period | - | - |
Beginning balance of cash and cash equivalents | - | - |
Ending balance of cash and cash equivalents | - | - |
項目 | 2024 | 2023 |
---|---|---|
Current asset | 2,974,170 | 1,807,168 |
Non-current asset | 123,124 | 141,805 |
Total asset | 3,097,294 | 1,948,973 |
Current liability | 2,084,965 | 1,080,989 |
Non-current liability | 19,083 | 30,900 |
Total liability | 2,104,048 | 1,111,889 |
share capital | 604,117 | 604,117 |
Equity - secruity token | - | - |
capital reserve | 187,330 | 187,330 |
retained earning | 201,799 | 45,637 |
Other equity | 0 | 0 |
Treasury stock | 0 | 0 |
Total equity attributable to owners of parent company | - | - |
Equity attributable to former owner of business combination under common control | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - |
Non-controlling interests | - | - |
Total Equity | 993,246 | 837,084 |
Share capital awaiting retirement (unit: share) | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 |
Net asset value per share | 16 | 13 |